Being a logistics service provider for the booming cell/gene therapy sector, Cryoport is enjoying the robust industry tailwind and thereby positioning itself to be an investment bonanza. Various acqui
Cryoport: Risky Investment With Upside Potential

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

10:20am, Tuesday, 29'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for XHE

Cryoport launches $100M stock repurchase program (NASDAQ:CYRX)

05:40am, Monday, 14'th Mar 2022 Seeking Alpha
Cryoport''s (CYRX) board has unanimously authorized a repurchase program, under which Cryoport may repurchase up to $100M of its outstanding common stock and/or convertible senior…

CryoPort Approves $100M Buyback Program

08:56pm, Friday, 11'th Mar 2022 Benzinga
CryoPort Inc''s (NASDAQ: CYRX ) Board has authorized a repurchase program . Per the program, CryoPort may repurchase up to $100 million of its outstanding common stock and/or convertible senior notes. The repurchase program … Full story available on Benzinga.com

New Strong Sell Stocks for March 10th

12:25pm, Thursday, 10'th Mar 2022 Zacks Investment Research
BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

11:20am, Thursday, 10'th Mar 2022 Zacks Investment Research
Sector ETF report for XHE

New Strong Sell Stocks for March 10th

09:02am, Thursday, 10'th Mar 2022
BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.

CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates

11:30pm, Thursday, 24'th Feb 2022 Zacks Investment Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

CryoPort GAAP EPS of -$5.46, revenue of $56.4M misses by $1.33M

09:40pm, Thursday, 24'th Feb 2022 Seeking Alpha
CryoPort press release (CYRX): Q4 GAAP EPS of -$5.46 may not be comparable to consensus of -$0.13.Revenue of $56.4M (+16.6% Y/Y) misses by $1.33M.Gross margin was 41.0% for the…
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Cryoport, Inc.'s (CYRX) CEO Jerrell Shelton on Q4 2021 Results - Earnings Call Transcript
CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in rev
CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in rev
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE